Alečković, M., Li, Z., Zhou, N., Qiu, X., Lulseged, B., Foidart, P., Huang, X.-Y., Garza, K., Shu, S., Kesten, N., Li, R., Lim, K., Garrido-Castro, A. C., Guerriero, J. L., Qi, J., Long, H. W., & Polyak, K. (01 November 2023). Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer. Molecular Cancer Therapeutics, 22 (11), 1304 - 1318. doi:10.1158/1535-7163.MCT-23-0303 |
Alečković, M., Cristea, S., Gil Del Alcazar, C. R., Yan, P., Ding, L., Krop, E. D., Harper, N. W., Rojas Jimenez, E., Lu, D., Gulvady, A. C., Foidart, P., Seehawer, M., Diciaccio, B., Murphy, K. C., Pyrdol, J., Anand, J., Garza, K., Wucherpfennig, K. W., Tamimi, R. M., ... Polyak, K. (07 December 2022). Breast cancer prevention by short-term inhibition of TGFβ signaling. Nature Communications, 13 (1), 7558. doi:10.1038/s41467-022-35043-5 |
Hamdi, J., FOIDART, P., & Ali, D. (2021). Mediastinal malposition of a catheter enhanced by an unusual stenosis of the left brachiocephalic vein due to a former long-term haemodialysis catheter. Journal of Medical Case Reports and Case Serie. |
Delmotte, V., Foidart, P., DE VOEGHT, A., LEJEUNE, M., & Delwaide, J. (2019). Diagnostic différentiel de l’anémie dans la cirrhose éthylique. Revue Médicale de Liège, 74 (10), 527-534. |
Marangoni, E., Laurent, C., Coussy, F., El Botty, R., Chateau-Joubert, S., Servely, J.-L., de Plater, L., Assayag, F., Dahmani, A., Montaudon, E., Nemati, F., Fleury, J., Vacher, S., Gentien, D., Rapinat, A., Foidart, P., Sounni, N. E., Noël, A., Salomon, A., ... Reyal, F. (2018). Capecitabine efficacy is correlated with TYMP and RB expression in PDX established from triple-negative breast cancers. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-17-3490 |
Yip, C., Foidart, P., Somja, J., Truong, A., Lienard, M., Feyereisen, E., SCHROEDER, H., GOFFLOT, S., Donneau, A.-F., COLLIGNON, J., Delvenne, P., Sounni, N. E., Jerusalem, G., & Noël, A. (2017). MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib. British Journal of Cancer. doi:10.1038/bjc.2017.23 |